GlassScriptPhysician profile
Matthew J Zinno
NPI 1831316447
$10,632.74
in general payments reported to CMS, 2019-2025
10 companies · $344 in 2025
The $344 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,822 · 2020: $1,760 · 2021: $4,668 · 2022: $1,529 · 2023: $186 · 2024: $324 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $5,786.26 | 2019-2025 | |
| Arthrex, INC. | $3,382.42 | 2019-2025 | |
| Smith+Nephew, INC. | $570.38 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Coblation, Spatial Frame |
| Stryker Corporation | $540.37 | 2019-2024 | Insignia, Mako |
| Pacira Therapeutics, INC. | $161.79 | 2019-2020 | |
| Axogen | $50.83 | 2023 | Avance Nerve Graft |
| Abbott Laboratories | $43.37 | 2021-2022 | |
| Vericel Corporation | $41.65 | 2021-2022 | |
| Bioventus LLC | $33.98 | 2023 | Durolane |
| Baxter Healthcare | $21.69 | 2024 | Perclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Zinno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.